TP53 acts as a tumor suppressor in cancer. It induces cell cycle arrest or apoptosis in response to cellular stress and damage. p53 gene alteration could cause uncontrolled cell proliferation. In the present study, we used TP53 gene as the seed in the construction of a protein-protein interaction network to identify genes that might involve in tumorgenesis process with TP53. TP53 protein interaction database was obtained from STRING version 9.1 program. High-throughput experimental data, literature data and hypothetical studies have been used to determine the roles of candidate genes in TP53 pathway. A total 500 genes from STRING database loaded into Cytoscape version 2.8.3. The 1762 protein interactions were assembled and visualized in y organic form. We found eight specific non-overlapping clusters of various sizes, which emerged from the huge network of protein-interactors using MCODE version 1.32 clustering algorithm. Biological Networks Gene Ontology (BiNGO) was used to determine two ontologies (molecular function and biological process) involved in the protein network. Most of the genes mainly participated in gene and protein expression, cell signaling and metabolism. A better understanding of the relationship between the genes could aid in developing prognostic markers and better therapeutic strategies in cancer treatment.
Introduction
According to World Cancer Factsheet (February 2017), cancer is one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases in 2012 (1). The number of new cases is expected to rise by about 70% over the next two decades. Moreover, lack of specific symptoms in the early stage of disease leading to delay in diagnosis. The success rate of conventional methods such as surgery, chemotherapy and radiotherapy to treat cancer has not been very high. Furthermore, these treatments could cause damage to normal cells, DNA which leads to mutation, mouth ulcerations, cognitive impairments, cardiomyopathy, liver failure, delayed nausea and kidney failure (2) . Thus, there is an urgency in developing new approaches for the treatment of cancer patients. Several important pathways are thought to be involved in cancer such as ErbB signaling pathway, PI3K-Akt signaling pathway, MAPK signaling pathway, PARP signaling pathway and p53 pathway. Cell cycle regulation is complex. Most of genes such as cyclins, cyclin dependent kinases, cyclin dependent inhibitors, protein kinases and tumor suppressor genes involved in cell cycle process and its regulation (3) . The TP53 acts as a tumor suppressor in cancer. It is an important gene that induces cell cycle arrest or apoptosis in response to cellular stress and damage. p53 gene alteration could cause uncontrolled proliferation of cell. Moreover, p53 related genes such as BCL2, MDM2 and BAX have been involved in tumorgenesis process via p53 pathway (4) (5) (6) . TP53 plays a vital role in cell cycle control and apoptosis. Defective p53 could allow proliferation of abnormal cells which resulting in cancer. Most of all human tumors consist of p53 mutants. In a normal cell, Akt, also known as protein kinase B (PKB), exists in an hypoactive state because of the low expression of HER2 or existence of functional phosphatase and tension homolog deleted on chromosome ten (PTEN) so the cell cycle progression remains through the negative G1 regulators such as nuclear p21/Cip1, WAF1, and p27Kip1. In addition, murine double minute gene 2 (MDM2) maintains in an inactive form. Therefore, it is unable to degrade p53 and activates the p21 Cip1/WAF1, which leading to G1 growth arrest and apoptosis. The p53 protein level is low. DNA damage and other stress signals may trigger the increase of p53 proteins, which have three major functions: growth arrest, DNA repair and apoptosis (cell death). The growth arrest stops the progression of cell cycle, preventing replication of damaged DNA. During the growth arrest, p53 may activate the transcription of proteins involved in DNA repair. Apoptosis is the "last resort" to avoid proliferation of cells containing abnormal DNA. In a cancer cell, Akt exists in a hyperactive form due to high expression of HER2 or mutated PTEN. As a result, Akt phosphorylates p21Cip1/WAF1 at Threonine 145 within the nuclear localization signal (NLS) region (7) (8) . This causes cytoplasmic retention of p21Cip1/WAF1 and enhanced cell survival. p21Cip1/WAF1 is a potent inhibitor of CDK2 that contributes to G1 growth arrest and apoptosis. Similar to p21Cip1/WAF1 activity, p27Kip1 is phosphorylated by Akt at Threonine 157 within the NLS region and remains in the cytoplasm, contributing to suppression of apoptosis. In addition, Akt also phosphorylates MDM2, a ubiquitin E3 ligase which induces its nuclear accumulation and p53 degradation ability, leading to down-regulated cell cycle progression and apoptosis. Researchers believed that many genes participated in the cell cycle regulation process are involved as promoter of tumorgenesis process. To understand the association of different genes and their protein products in the etiology of disease, the function played by interactions between p53 and genes that participated in different types of other pathways in the carcinogenesis process should be studied. Recently, molecular network are being used to predict novel possible genes depend on the hypothesis that genes that lie in the neighborhood of disease causing genes in the network are likely to be associated with same or similar disease (9) . Based on Goehler (10) and Jonsson and Bates (11) studies, they have been demonstrated that novel disease genes were identified via the proteinprotein interaction networks. Besides that, they indicated that genes involved in TP53 pathway are highly interconnected (12) (13) . Hence, one biomolecule alteration might affect the functioning of other associated biomolecules. Moreover, Jayaraman and his co-workers identified that the TP53 gene was conserved across the mammalian genome using phylogenetic methods (14) . TP53 gene alteration was probably because of the changes that accumulated during the evolutionary history of this gene. A better understanding of the TP53 biological networking will help in studying deregulations in TP53 pathway. Therefore, the objective of this study was to analyze the functional interactions of p53 gene and its interacting proteins.
Materials and Methods
Identification of genes involved in TP53 pathway STRING version 9.1 program was used to find the genes participated in pathway of TP53 (15) . This tool was selected because it has an extensive collection of precomputed interaction data derived from different types of sources such as high-throughput experimental data, literature review data and predictions of computational; probalistic scoring was used to score the network interactions for getting higher confidence (>90%) in the interactions and; allows grouping of the interacting molecules into clusters using MCODE algorithms in the advanced mode. Neighbourhood, gene fusion, cooccurrence, co-expression, experiments, databases and text mining were chosen as the prediction methods in this analysis. The interactions which had a confidence score greater than 0.9, representing more than 80-90% confidence in the predictions was also filtered in this analysis (16) .
Clustering of p53 gene analysis
MCODE version 1.32 clustering algorithm is one of the plugins in Cytoscape version 2.8.3 software. It was used for p53 gene clustering analysis. The MCODE version 1.32 clustering algorithm was applied to segregate the network into smaller subgroups of eight clusters. A cluster is a set of objects which share some common characteristics. In protein-protein interaction networks, clusters correspond to two types of modules: protein complexes and functional modules. Protein complexes are groups of proteins that interact with each other at the same time and place, forming a single multi-molecular machine. Functional modules consist of proteins that participate in a particular cellular process while binding to each other at a different time and place. Clustering in protein-protein interaction networks therefore involves identifying protein complexes and functional modules. This process has the following analytical benefits (17):
(1) clarification of PPI network structures and their component relationships;
(2) inference of the principal function of each cluster from the functions of its members; (3) elucidation of possible functions of members in a cluster through comparison with the functions of other members. The MCODE algorithm operates in three steps: vertex weighting, complex prediction, and optional postprocessing to filter or add proteins to the resulting complexes (17) .
Determination of molecular function and biological processes of the genes involved in TP53 protein network
TP53 protein network was evaluated with BiNGO program which is embedded within the Cytoscape version 2.8.3 software. It was carried out to determine the molecular function and biological processes of the TP53 protein network.
Results

Identification of genes involved in TP53 pathway using STRING version 9.1 program
In this study, TP53 gene was used as the seed in the construction of a protein-protein functional association network to identify genes that might involve in tumorgenesis process with TP53. TP53 protein interaction database was obtained from STRING version 9.1 program. High-throughput experimental data, literature data and hypothetical studies have been used to determine the roles of candidate genes in TP53 pathway. In addition, STRING program also scores the network interactions using probabilistic scoring to get higher confidence in the interactions. In this study, hypothetical studies defined as prediction of proteinprotein interaction based on text mining. Therefore, combination of databases from experimental and prediction sources provide a wider base for analyzing the protein interactome. A sum of 500 interacting Downloaded from pbr.mazums.ac.ir at 3:01 +0330 on Tuesday October 15th 2019 Pharm Biomed Res 2018; 4(3): 11 proteins with 1762 interactions was obtained from the database. Figure 1 shows the highly connected network of molecules. The protein-protein interaction was represented as network graph with proteins as nodes and interactions as edges. Most of genes were situated at the center of the network whereas few molecules loosely arranged at the periphery. Some of the interactors are connected to one another by multiple lines which represent interactions derived from more than one source of databases.
Gene clustering analysis using MCODE version 1.32 algorithm Firstly, a total 500 genes from STRING database loaded into Cytoscape version 2.8.3 software. The 1762 protein interactions were assembled and visualized in y organic form. The MCODE version 1.32 clustering algorithm was applied to segregate the network into smaller subgroups of eight clusters ( Figure 2 ). Table 1 shows clustering results of TP53 protein.
Evaluation of TP53 protein network using BiNGO analysis
After that, the TP53 protein network was analyzed with the BiNGO program which is one of the plugins in Cytoscape version 2.8.3 software. BiNGO was used to determine two ontologies (molecular function and biological process) involved in the protein network. Detail results were displayed in Table 2 and Figure S1 .
Discussion
A highly connected network of 35 protein molecules was found in the first cluster. This cluster has more interactions with other proteins when compared with all other clusters. The proteins possess a wide range of functional attributes. Furthermore, TP53 is part of this cluster. This dense cluster consists of proteins of TP53 binding (CDKN2A, BLM, MDM2), cyclins (CDK1), cyclin dependent kinases (CDK1, CDK7), tumor suppressors (TP53), transcriptional activators (MAX, NOTCH1, AR, KAT2B, HDAC1, YY1, TP53, BRCA2, SMAD2, CDK7, STAT3, BRCA1, TGFB1), transcription factors (AR, KAT2B, CREB1, YY1, TP53, ESR1, SMAD2, CDK7, BRCA1, STAT3, MAPK1, MAX, HIF1A, CDKN2A, HDAC1), apoptosis regulators (TP53, MDM2), HIFIA regulators (HIF1A, TP53), cell cycle regulators (MAPK1, NOTCH1, AR, HIF1A, CD44, PLK1, MAPK14, ESR1, SMAD2, STAT3), DNA repair (NOTCH1, BLM, CREB1, TP53, BRCA2, MLH1, SMAD2), heat shock protein binding (CDK1, HIF1A) and many ubiquitin proteins. Some important genes' functions were described as below. The cyclins and cyclin dependent kinase proteins are playing role in control of cell cycle progression. The alteration of these proteins affects progression and contributes to the uncontrolled cell proliferation which leads to cancer. CDKN2A protein is a key cell cycle protein. It is capable to enhance cell cycle arrest in G1 and G2 phases. It also acts as a tumor suppressor. It binds to MDM2 and blocks its nucleoplasmic shuttling by sequestering it in the nucleolus. This inhibits the oncogenic action of MDM2 by blocking MDM2-induced degradation of p53 and enhancing p53-dependent transactivation and apoptosis. It also induces G2 arrest and apoptosis in a p53-independent manner by preventing the activation of cyclin B1/CDC2 complexes. It binds to BCL6 and down-regulates BCL6-induced transcriptional repression. BRCA1 plays an essential function in DNA damage repair. It also required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Besides that, it also participated in p21 transcriptional regulation in response to DNA damage; to maintain the genomic stability. While, BRCA2 involved in double-strand break repair and homologous recombination. BAX induces apoptosis through binding to, and antagonizing the apoptosis repressor BCL2 or its adenovirus homolog E1B 19 kDa protein. Programmed cell death is accelerated by the cytochrome C release and CASP3 activation. PTEN is also a tumor suppressor protein. It acts as a dual-specificity protein phosphatase, dephosphorylating tyrosine-, serine-and threoninephosphorylated proteins. Apart from that, it also acts a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3,4diphosphate, phosphatidylinositol 3-phosphate and inositol 1,3,4,5-tetrakisphosphate with order of substrate preference in vitro PtdIns(3,4,5)P3 > PtdIns(3,4)P2 > PtdIns3P > Ins(1,3,4,5)P4. The lipid phosphatase activity is crucial for its tumor. Notch1 plays role as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Notch intracellular domain (NCID) forms a transcriptional activator complex with RBP-J kappa through activation of ligand. Then, it activates genes of the enhancer of split locus. It hinders the differentiation implementation, proliferation and apoptotic process. The alteration of this gene contributes to transformation or progression in some T-cell neoplasms. HIF1A acts a master transcriptional regulator of the adaptive response to hypoxia. Under hypoxic conditions, it activates the transcription genes such as erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor genes to facilitate metabolic adaptation to hypoxia. It plays crucial role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. MDM2 is a negative regulator of TP53 protein which defines that it inhibits p53 and p73-mediated cell cycle arrest and apoptosis via binding its transcriptional activation domain. Therefore, it stabilized p53 protein through ubiquitination and permits p53 export for proteasome-mediated proteolysis. Moreover, p53 inactivation affects tumor suppression activity of p53. In differentiated cells, MAPK1 participated in both the initiation and regulation of meiosis, mitosis and post mitotic functions via phosphorylating a number of transcription factors including ELK1. It also plays role in translation initiation through phosphorylation of E1F4BP1. In the second cluster, 19 proteins play a variety of roles such as transcriptional activators, transcription factors, signal transducers, cyclin dependent kinases; and involved in cell growth, apoptosis, metabolism, differentiation and angiogenesis processes. Several essential genes in this cluster were explained as follows. Akt1 is a general protein kinase that capable of phosphorylating several known proteins including TBC1D4. It signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). MYC plays an important role in regulates transcription of several genes that participated in a wide variety of functions including cell growth, metabolism, programmed cell-death, cell cycle, angiogenesis and differentiation. Alteration of this protein contributes not only its expression but also various target genes and their pathways. In spite of this, alteration of this protein has been reported in several cancers. FOS is a nuclear phospho-protein which forms a tight but non-covalently linked complex with JUN/AP-1 transcription factor. It acts as a regulator for the development of cells destined to form and maintain the skeleton. In addition, it also has a crucial role in transduction of signal, cell proliferation and differentiation. VEGFA protein is a growth factor which participated actively in angiogenesis, vasculogenesis through mediation of vascular permeability and endothelial cell growth. Angiogenesis is a physiological process via which new blood vessels form from the old vessels. It also induces cell migration and inhibits apoptosis. This protein plays a critical function in Downloaded from pbr.mazums.ac.ir at 3:01 +0330 on Tuesday October 15th 2019 bone marrow angiogenesis through binding to VEGF receptors. EGFR is an oncogene homolog and acts receptor for EGF and other members of the EGF family including TGF-alpha, amphiregulin, betacellulin, heparinbinding EGF-like growth factor, GP30 and vaccinia virus g rowth factor. Furthermore, it also involved in the cell growth control and differentiation. Third cluster comprises 34 proteins that functionally active in binding of protein, DNA, death receptor, ATP, BH3 domain; and plays crucial role in cell cycle, programmed cell-death, transcription repressor activity and organelle organization. This gene encodes a transcription factor that involves in apoptosis in response to cellular stress, stimulus and DNA damage. Two vital genes (BCL2 and BID) involved in this cluster. BCL2 protein is involved in regulation of cell death through controlling mitoch ondrial membrane permeability. It plays an important role in a feedback loop system with caspases. It inhibits caspase activity either via preventing the release of cytochrome c from the mitochondrio or through binding to the apoptosis-activating factor (APAF1). BID counters the protective effect of BCL2. The major proteolytic product p15BID allows the cytochrome c release which is important for caspase activity. In forth cluster, the proteins were mainly involved in cell cycle, cell proliferation, apoptosis and regulation of transcription. This protein influence cell cycle arrest and programmed in response to cellular stress, ionizing radiation, toxin and DNA damage. However, the proteins in fifth cluster were actively participated in regulation of transcription, RNA metabolic process, macromolecule biosynthetic process, nucleobase, nucleosides, nucleotides and nucleic acid metabolic process and regulation of nitrogen compound metabolic process. On the other hand, the proteins in sixth cluster normally play key roles in organelle organization, chromatin organization and chromosome organization, chromatin assembly and disassembly, histone modification and covalent chromatin modification whereas proteins in cluster 7 mainly involved in induction of apoptosis by extracellular signals, membrane protein intracellular domain proteolysis, membrane protein proteolysis, regulation of cell differentiation and developmental process. Finally, cluster 8 associated with proteins usually participated in gene silencing by RNA, RNA processing, RNA metabolic process and rRNA catabolic process. Protein-protein interactions play a key role in different types of biological processes such as cell cycle, metabolic pathways and signal transduction (18) (19) . Therefore, studying these protein-protein interactions is notable. This is because it can reveal information about the regulation of cellular activities. Ciriello and his colleagues (2013) derived a hierarchical classification of 3,299 TCGA (20) tumors from twelve different types of cancer. The top classes are dominated by either mutations (M class) or alteration of copy number (C class). This significance is clearest at the extremes of genomic instability, which shows the presence of different oncogenic processes. The hierarchy describes the targetable functional events in tumor. Based on their study, TP53 mutations were strongly enriched in the C class. These mutations causing copy number genomic instability. Breast, ovarian, lung squamous cell, head and neck squamous cancer and endometrioid tumors of the serous subtype are included in C class. The C class subdivided into two groups, primarily determined by the absence (subclasses C1-C6) or presence (subclasses C7-C14) of gains and losses on chromosome 8. A major portion of lung cancer consists of subclass C3 while subclass C4 included a large fraction of head and neck squamous cancer. This proved as an example of cross-cancer similarity, in which alterations of genomics are shared by subsets of tumors of different origin. In lung cancer, subclass C3 was classified by mutation of TP53, copy number amplification of 3q26 and deletion of CDKN2A; whereas subclass C4 in head and neck squamous cancer had focal chromosomal copy number amplification of 11q13 where CCND1 is located. Some of these genomic differences actually converged on the same pathway, as loss of CDKN2A (C3) and gain of (H) Cluster 8 In breast and ovarian cancer, alteration of copy number in subclasses C7-C14 affects the cell cycle regulation and DNA damage response pathways. The G1/S phase checkpoint was compromised by amplification of CCNE1 in subclasses C7 and C11. Then, it was bypassed by amplification of E2F3 in subclass C13. Inactivation of BRCA1 and BRCA2 genes were caused by defective cell cycle arrest and DNA damage in subclass C13. Lastly, amplification and overexpression of the regulator of mitosis AURKA was occurred in subclass C14 (21) (22) . Alterations in the protein of p53 pathway might cause disruption of the pathway and thus might be significant contributors to the tumorigenesis process. For example, the blockade of the cell cycle and PI3K-AKT signalling in lung and head and neck squamous cell cancer; and inhibition of PARP and AURKA which causes the inactivation of BRCA1 or BRCA2 in breast and ovarian cancer prevent the proliferation of cancer cells and the abnormal cells undergo apoptosis.
Conclusion
In this study, the TP53 protein network analysis proved that the core regulation of p53 was stabilized via its interaction with several proteins. However, the proteins were functionally interacted with each other so alteration of protein might disrupt expression of interacting proteins and leads to the pathogenesis of disease. Exploring about gene expression in TP53 protein network could aid in identifying new pathways of disease pathogenesis. Besides that, a better understanding of the relationship between the genes could aid in developing prognostic markers and better therapeutic strategies in breast cancer treatment.
